October 6, 2008 -- The treatment according to his US Physician  was so successful he will not require the liver transplant he was scheduled for in the near future. The most visibly apparent change has been in his appearance due to a drop in his bilirubin level from 6 to a 2 which is close to normal for person of his build and height. It has returned  his skin from yellowish to a normal healthy look. In addition, his meld score has dropped in a short period of time from 20 to below 16 and is quickly heading lower.

The treatment was arranged by Stem Cell Regenco, a Silicon Valley company headed by a Stanford law school graduate that holds exclusive rights to the Russian stem cell treatment protocol of  Dr. GT. Sukhikh one of the world’s foremost stem cell physcians.  The treatment is in lieu of a liver transplant and eliminates the danger of a liver rejection and the necessity of taking organ anti-rejection drugs for the rest of a patients life at a cost of $12,000 a year. It is particularly effective in repairing liver damage caused by hepatitis B , C and Cerrosis.

Media Contact:
Jan STEVENS
408-269-0445
This email address is being protected from spam bots, you need Javascript enabled to view it
www.stemcellregenco.com

###